ADD1 (Human) Recombinant Protein (P01)

Total Page：16

File Type：pdf, Size：1020Kb

Produktinformation Diagnostik & molekulare Diagnostik Laborgeräte & Service Zellkultur & Verbrauchsmaterial Forschungsprodukte & Biochemikalien Weitere Information auf den folgenden Seiten! See the following pages for more information! Lieferung & Zahlungsart Lieferung: frei Haus Bestellung auf Rechnung SZABO-SCANDIC Lieferung: € 10,- HandelsgmbH & Co KG Erstbestellung Vorauskassa Quellenstraße 110, A-1100 Wien T. +43(0)1 489 3961-0 Zuschläge F. +43(0)1 489 3961-7 [email protected] • Mindermengenzuschlag www.szabo-scandic.com • Trockeneiszuschlag • Gefahrgutzuschlag linkedin.com/company/szaboscandic • Expressversand facebook.com/szaboscandic ADD1 (Human) Recombinant Protein Glutathione, pH=8.0 in the elution buffer. (P01) Storage Instruction: Store at -80°C. Aliquot to avoid repeated freezing and thawing. Catalog Number: H00000118-P01 Entrez GeneID: 118 Regulation Status: For research use only (RUO) Gene Symbol: ADD1 Product Description: Human ADD1 full-length ORF ( AAH42998, 1 a.a. - 662 a.a.) recombinant protein with Gene Alias: ADDA, MGC3339, MGC44427 GST-tag at N-terminal. Gene Summary: Adducins are a family of cytoskeleton Sequence: proteins encoded by three genes (alpha, beta, gamma). MNGDSRAAVVTSPPPTTAPHKERYFDRVDENNPEYL Adducin is a heterodimeric protein that consists of RERNMAPDLRQDFNMMEQKKRVSMILQSPAFCEELE related subunits, which are produced from distinct genes SMIQEQFKKGKNPTGLLALQQIADFMTTNVPNVYPAAP but share a similar structure. Alpha- and beta-adducin QGGMAALNMSLGMVTPVNDLRGSDSIAYDKGEKLLR include a protease-resistant N-terminal region and a CKLAAFYRLADLFGWSQLIYNHITTRVNSEQEHFLIVPF protease-sensitive, hydrophilic C-terminal region. Alpha- GLLYSEVTASSLVKINLQGDIVDRGSTNLGVNQAGFTL and gamma-adducins are ubiquitously expressed. In HSAIYAARPDVKCVVHIHTPAGAAVSAMKCGLLPISPE contrast, beta-adducin is expressed at high levels in ALSLGEVAYHDYHGILVDEEEKVLIQKNLGPKSKVLILR brain and hematopoietic tissues. Adducin binds with high NHGLVSVGESVEEAFYYIHNLVVACEIQVRTLASAGGP affinity to Ca(2+)/calmodulin and is a substrate for DNLVLLNPEKYKAKSRSPGSPVGEGTGSPPKWQIGEQ protein kinases A and C. Alternative splicing results in EFEALMRMLDNLGYRTGYPYRYPALREKSKKYSDVEV multiple variants encoding distinct isoforms; however, PASVTGYSFASDGDSGTCSPLRHSFQKQQREKTRWL not all variants have been fully described. [provided by NSGRGDEASEEGQNGSSPKSKTKWTKEDGHRTSTSA RefSeq] VPNLFVPLNTNPKEVQEMRNKIREQNLQDIKTAGPQS QVLCGVVMDRSLVQDAPLSDCTETIEGLELTEQTFSPA KSLSFRKGELVTASKAIIEKEYQPHVIVSTTGPNPFTTL TDRELEEYRREVERKQKGSEENLDEAREQKEKSPPD QPAVPHPPPSTPIKLEEGDGCAREYLLP Host: Wheat Germ (in vitro) Theoretical MW (kDa): 98.56 Applications: AP, Array, ELISA, WB-Re (See our web site product page for detailed applications information) Protocols: See our web site at http://www.abnova.com/support/protocols.asp or product page for detailed protocols Preparation Method: in vitro wheat germ expression system Purification: Glutathione Sepharose 4 Fast Flow Storage Buffer: 50 mM Tris-HCI, 10 mM reduced Page 1/1 Powered by TCPDF (www.tcpdf.org).

Copy Link

Recommended publications

FK506-Binding Protein 12.6/1B, a Negative Regulator of [Ca2+], Rescues Memory and Restores Genomic Regulation in the Hippocampus of Aging Rats
This Accepted Manuscript has not been copyedited and formatted. The final version may differ from this version. A link to any extended data will be provided when the final version is posted online. Research Articles: Neurobiology of Disease FK506-Binding Protein 12.6/1b, a negative regulator of [Ca2+], rescues memory and restores genomic regulation in the hippocampus of aging rats John C. Gant1, Eric M. Blalock1, Kuey-Chu Chen1, Inga Kadish2, Olivier Thibault1, Nada M. Porter1 and Philip W. Landfield1 1Department of Pharmacology & Nutritional Sciences, University of Kentucky, Lexington, KY 40536 2Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294 DOI: 10.1523/JNEUROSCI.2234-17.2017 Received: 7 August 2017 Revised: 10 October 2017 Accepted: 24 November 2017 Published: 18 December 2017 Author contributions: J.C.G. and P.W.L. designed research; J.C.G., E.M.B., K.-c.C., and I.K. performed research; J.C.G., E.M.B., K.-c.C., I.K., and P.W.L. analyzed data; J.C.G., E.M.B., O.T., N.M.P., and P.W.L. wrote the paper. Conflict of Interest: The authors declare no competing financial interests. NIH grants AG004542, AG033649, AG052050, AG037868 and McAlpine Foundation for Neuroscience Research Corresponding author: Philip W. Landfield, [email protected], Department of Pharmacology & Nutritional Sciences, University of Kentucky, 800 Rose Street, UKMC MS 307, Lexington, KY 40536 Cite as: J. Neurosci ; 10.1523/JNEUROSCI.2234-17.2017 Alerts: Sign up at www.jneurosci.org/cgi/alerts to receive customized email alerts when the fully formatted version of this article is published.
[Show full text]
ADD1 Pt445) Antibody Catalogue No.:Abx326604
Datasheet Version: 1.0.0 Revision date: 02 Nov 2020 Alpha Adducin Phospho-Thr445 (ADD1 pT445) Antibody Catalogue No.:abx326604 Alpha Adducin (ADD1) (pT445) Antibody is a Rabbit Polyclonal against Alpha Adducin (ADD1) (pT445). Adducins are a family of cytoskeletal proteins encoded by three genes (alpha, beta, and gamma). Adducin acts as a heterodimer of the related alpha, beta, or gamma subunits. The protein encoded by this gene represents the alpha subunit. Alpha- and beta-adducin include a protease-resistant N-terminal region and a protease-sensitive, hydrophilic C-terminal region. Adducin binds with high affinity to Ca(2+)/calmodulin and is a substrate for protein kinases A and C. Target: Alpha Adducin Phospho-Thr445 (ADD1 pT445) Clonality: Polyclonal Target Modification: Thr445 Modification: Phosphorylation Reactivity: Human, Mouse, Rat Tested Applications: ELISA, IHC Host: Rabbit Recommended dilutions: IHC: 1/100 - 1/300, ELISA: 1/5000. Optimal dilutions/concentrations should be determined by the end user. Conjugation: Unconjugated Immunogen: Synthesized peptide derived from human Adducin α around the phosphorylation site of T445. Isotype: IgG Form: ForLiquid Reference Only Purification: Affinity Chromatography. Storage: Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. UniProt Primary AC: P35611 (UniProt, ExPASy) Q9QYC0 (UniProt, ExPASy) Gene Symbol: ADD1 GeneID: 118 v1.0.0 Abbexa Ltd, Cambridge, UK · Phone: +44 1223 755950 · Fax: +44 1223 755951 1 Abbexa LLC, Houston, TX, USA · Phone: +1 832 327 7413 www.abbexa.com ·
[Show full text]
The Unfolded Protein Response and Its Potential Role In
F1000Research 2015, 4:103 Last updated: 22 JUL 2020 RESEARCH ARTICLE The unfolded protein response and its potential role in Huntington ́s disease elucidated by a systems biology approach [version 1; peer review: 2 approved] Ravi Kiran Reddy Kalathur1, Joaquin Giner-Lamia1, Susana Machado1, Kameshwar R S Ayasolla1, Matthias E. Futschik1,2 1Centre for Biomedical Research, University of Algarve, Faro, 8005-139, Portugal 2Centre of Marine Sciences, University of Algarve, Faro, 8005-139, Portugal First published: 01 May 2015, 4:103 Open Peer Review v1 https://doi.org/10.12688/f1000research.6358.1 Latest published: 02 Mar 2016, 4:103 https://doi.org/10.12688/f1000research.6358.2 Reviewer Status Abstract Invited Reviewers Huntington ́s disease (HD) is a progressive, neurodegenerative disease 1 2 with a fatal outcome. Although the disease-causing gene (huntingtin) has been known for over 20 years, the exact mechanisms leading to neuronal version 2 cell death are still controversial. One potential mechanism contributing to (revision) report the massive loss of neurons observed in the brain of HD patients could be 02 Mar 2016 the unfolded protein response (UPR) activated by accumulation of misfolded proteins in the endoplasmic reticulum (ER). As an adaptive response to counter-balance accumulation of un- or misfolded proteins, the version 1 UPR upregulates transcription of chaperones, temporarily attenuates new 01 May 2015 report report translation, and activates protein degradation via the proteasome. However, persistent ER stress and an activated UPR can also cause apoptotic cell death. Although different studies have indicated a role for the Scott Zeitlin, University of Virginia, UPR in HD, the evidence remains inconclusive.
[Show full text]
Pharmacogenomics and Pharmacogenetics of Hypertension: Update and Perspectives—The Adducin Paradigm
Pharmacogenomics and Pharmacogenetics of Hypertension: Update and Perspectives—The Adducin Paradigm Paolo Manunta and Giuseppe Bianchi Division of Nephrology, Dialysis and Hypertension, University “Vita-Salute” San Raffaele Hospital, Milan, Italy There is a growing literature on the potential prospective use of genome information to enhance success in finding new medicines. An example of a prospective efficacy of pharmacogenetic and pharmacogenomics is the detection and impact of adducin polymorphism on hypertension. Adducin is a heterodimeric cytoskeleton protein, the three subunits of which are encoded by genes (ADD1, ADD2, and ADD3) that map to three different chromosomes. A long series of parallel studies in the Milan hypertensive rat strain model of hypertension and humans indicated that an altered adducin function might cause hypertension through an enhanced constitutive tubular sodium reabsorption. In particular, six linkage studies, 18 of 20 association studies, and four of five follow-up studies that measured organ damage in hypertensive patients support the clinical impact of adducing polymorphism. As many modulatory genes and environment affect the adducin activity, the context must be taken into account to measure the clinical effect size of adducins. Pharmacogenomics is giving an important contribution to this end. In particular, the selective advantages of diuretics in preventing myocardial infarction and stroke over other antihypertensive therapies that produce a similar BP reduction in carriers of the mutated adducin may support new strategies that aim to optimize the use of antihypertensive agents for the prevention of hypertension-associated organ damage. J Am Soc Nephrol 17: S30–S35, 2006. doi: 10.1681/ASN.2005121346 he enormous variation in the individual response to optimal goal levels seems to be more important than specific antihypertensive treatment has led to acceleration of drug selection.
[Show full text]
The Tissue-Specific Transcriptomic Landscape of the Mid-Gestational Mouse Embryo Martin Werber1, Lars Wittler1, Bernd Timmermann2, Phillip Grote1,* and Bernhard G
© 2014. Published by The Company of Biologists Ltd | Development (2014) 141, 2325-2330 doi:10.1242/dev.105858 RESEARCH REPORT TECHNIQUES AND RESOURCES The tissue-specific transcriptomic landscape of the mid-gestational mouse embryo Martin Werber1, Lars Wittler1, Bernd Timmermann2, Phillip Grote1,* and Bernhard G. Herrmann1,3,* ABSTRACT mainly protein-coding genes. However, none of these datasets has Differential gene expression is a prerequisite for the formation of multiple provided an accurate representation of the transcriptome of the mouse cell types from the fertilized egg during embryogenesis. Understanding embryo. In particular, earlier studies using expression profiling did not the gene regulatory networks controlling cellular differentiation requires cover the complete set of protein coding genes or alternative transcripts the identification of crucial differentially expressed control genes and, or noncoding RNA genes. The latter have come into focus in recent ideally, the determination of the complete transcriptomes of each years, as noncoding genes are assumed to play important roles in gene individual cell type. Here, we have analyzed the transcriptomes of six regulation (for reviews, see Pauli et al., 2011; Rinn and Chang, 2012). major tissues dissected from mid-gestational (TS12) mouse embryos. Among the highly diverse class of noncoding genes, long Approximately one billion reads derived by RNA-seq analysis provided noncoding RNAs (lncRNAs) are thought to influence transcription extended transcript lengths, novel first exons and alternative transcripts by a wide range of mechanisms. For example, lncRNAs can interact of known genes. We have identified 1375 genes showing tissue-specific with chromatin-modifying protein complexes involved in gene expression, providing gene signatures for each of the six tissues.
[Show full text]
Orbitofrontal Neuroadaptations and Cross-Species Synaptic Biomarkers in Heavy-Drinking Macaques
3646 • The Journal of Neuroscience, March 29, 2017 • 37(13):3646–3660 Neurobiology of Disease Orbitofrontal Neuroadaptations and Cross-Species Synaptic Biomarkers in Heavy-Drinking Macaques X Sudarat Nimitvilai,1* Joachim D. Uys,2* John J. Woodward,1,3 Patrick K. Randall,3 Lauren E. Ball,2 X Robert W. Williams,4 XByron C. Jones,4 X Lu Lu,4 X Kathleen A. Grant,5 and Patrick J. Mulholland1,3 Departments of 1Neuroscience, 2Cell and Molecular Pharmacology, and 3Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina 29425, 4Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, Tennessee 38120, and 5Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, Oregon 97239 Cognitive impairments, uncontrolled drinking, and neuropathological cortical changes characterize alcohol use disorder. Dysfunction of the orbitofrontal cortex (OFC), a critical cortical subregion that controls learning, decision-making, and prediction of reward outcomes, contributes to executive cognitive function deficits in alcoholic individuals. Electrophysiological and quantitative synaptomics tech- niques were used to test the hypothesis that heavy drinking produces neuroadaptations in the macaque OFC. Integrative bioinformatics and reverse genetic approaches were used to identify and validate synaptic proteins with novel links to heavy drinking in BXD mice. In drinking monkeys, evoked firing of OFC pyramidal neurons was reduced, whereas the amplitude and frequency of postsynaptic currents were enhanced compared with controls. Bath application of alcohol reduced evoked firing in neurons from control monkeys, but not drinking monkeys. Profiling of the OFC synaptome identified alcohol-sensitive proteins that control glutamate release (e.g., SV2A, synaptogyrin-1) and postsynaptic signaling (e.g., GluA1, PRRT2) with no changes in synaptic GABAergic proteins.
[Show full text]
Aberrant Alternative Splicing and Extracellular Matrix Gene Expression in Mouse
Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Hongqing Du1, Melissa S. Cline1, Robert J. Osborne2, Daniel L. Tuttle3, Tyson A. Clark4, John Paul Donohue1, Megan P. Hall1, Lily Shiue1, Maurice S. Swanson3, Charles A. Thornton2, and Manuel Ares, Jr.1* 1RNA Center, Department of Molecular, Cell and Developmental Biology, Sinsheimer Labs, University of California, Santa Cruz, California 95064 USA 2Neuromuscular Disease Center, Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642 USA 3Department of Molecular Genetics & Microbiology, University of Florida, College of Medicine, Gainesville, FL 32610 USA 4Affymetrix Inc, Santa Clara, CA 95051 USA SUPPLEMENTARY FIGURES AND TABLES Nature Structural & Molecular Biology: doi:10.1038/nsmb.1720 Nature Structural & Molecular Biology: doi:10.1038/nsmb.1720 Supplementary Figure 1 Validation and comparison of mis-spliced events in quadriceps samples of HSALR and MBNL1ΔE3/ΔE3 mice. RT-PCR fragments were separated on 2.5% agarose gel. The mis- splicing events validated by RT-PCR were classified (a-c): 28 RT-PCR validations of mis-splicing cassette exon events predicted by splicing microarray to be altered in both HSALR and MBNL1ΔE3/ΔE3 mice (a); 4 mis-spliced cassette exon events altered only in MBNL ΔE3/ΔE3 mice (b); 1 mis-splicing cassette exon event altered only in HSALR mice (c). (d) Comparison of separation score of altered splicing events predicted by RT-PCR in both HSALR mice and MBNL1ΔE3/ΔE3 mice (R2 = 0.88). Separation score for RT-PCR data were calculated using amounts determined by the Bioanalyzer. Nature Structural & Molecular Biology: doi:10.1038/nsmb.1720 Supplementary Figure 2 Mapping binding motifs for other splicing factors.
[Show full text]
Polyclonal Antibody to ADD1 (Phospho-Ser726)
9853 Pacific Heights Blvd. Suite D. San Diego, CA 92121, USA Tel: 858-263-4982 Email: [email protected] 35-1172: Polyclonal Antibody to ADD1 (Phospho-Ser726) Clonality : Polyclonal Application : WB,IHC,IF Reactivity : Human,Mouse,Rat Gene : ADD1 Gene ID : 118 Uniprot ID : P35611 Format : Purified Alternative Name : ADDA, Erythrocyte adducin alpha subunit Isotype : Rabbit IgG Peptide sequence around phosphorylation site of serine 726 (T-P-S(p)-F-L) derived from Human Immunogen Information : ADD1. Description Adducins are a family of cytoskeleton proteins encoded by three genes (a, beta, gamma). Adducin is a heterodimeric protein that consists of related subunits, which are produced from distinct genes but share a similar structure. a- and beta-adducin include a protease-resistant N-terminal region and a protease-sensitive, hydrophilic C-terminal region. a- and gamma-adducins are ubiquitously expressed. In contrast, beta-adducin is expressed at high levels in brain and hematopoietic tissues. Adducin binds with high affinity to Ca(2+)/calmodulin and is a substrate for protein kinases A and C. Alternative splicing results in multiple variants encoding distinct isoforms; however, not all variants have been fully described. Product Info Amount : 50 µg / 100 µg Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM Content : NaCl, 0.02% sodium azide and 50% glycerol. Store the antibody at 4°C, stable for 6 months. For long-term storage, store at -20°C. Avoid Storage condition : repeated freeze and thaw cycles. Application Note Predicted MW: 130kd, Western blotting: 1:500~1:1000, Immunohistochemistry: 1:50~1:100, Immunofluorescence: 1:100~1:200 Figure 1: Western blot analysis of extracts from Hela cells using ADD1(Phospho- Ser726) Antibody 35-1172 and the same antibody preincubated with blocking peptide.
[Show full text]
Adducin in Tumorigenesis and Metastasis
www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 29), pp: 48453-48459 Review Adducin in tumorigenesis and metastasis Cong Luo1 and Jiayu Shen2 1Zhejiang Cancer Hospital, Department of Abdominal oncology, Hangzhou, Zhejiang, China 2Zhejiang Chinese Medical University, The Second Clinical Medical College, Hangzhou, Zhejiang, China Correspondence to: Cong Luo, email: [email protected] Keywords: adducin, phosphorylation, tumor Received: November 16, 2016 Accepted: March 28, 2017 Published: April 18, 2017 Copyright: Luo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Adducin is a membrane-skeletal protein localized at spectrin-actin junctions, involving in the formation of the network of cytoskeleton, cellular signal transduction, ionic transportation, cell motility and cell proliferation. While previous researches focused mainly on the relationship between adducin and hypertension, there are few studies focusing on the role of adducin in tumor. Previous studies showed that adducin played a role in the evolution and progression of neoplasm. This review makes a brief summary on the structure, function and mechanism of adducin and how adducin functions in tumorigenesis and metastasis. INTRODUCTION Human ADD2 is localized at chromosome 2p13-p14 [5], whereas ADD3 is on chromosome 10q24.2-24.3[6]. Adducin is a ubiquitously expressed membrane- The sequences of α adducin and β adducin share 66% skeletal protein, which was firstly extracted from human similarity at amino acid level, while γ adducin displays erythrocyte in 1986 [1].
[Show full text]
ADD1 Antibody (Center) Purified Rabbit Polyclonal Antibody (Pab) Catalog # Ap22310c
10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 ADD1 Antibody (Center) Purified Rabbit Polyclonal Antibody (Pab) Catalog # AP22310c Specification ADD1 Antibody (Center) - Product Information Application WB, FC,E Primary Accession P35611 Other Accession Q5RA10 Reactivity Human Host Rabbit Clonality polyclonal Isotype Rabbit Ig Calculated MW 80955 ADD1 Antibody (Center) - Additional Information Gene ID 118 Other Names Alpha-adducin, Erythrocyte adducin subunit alpha, ADD1, ADDA All lanes : Anti-ADD1 Antibody (Center) at 1:2000 dilution Lane 1: 293 whole cell lysate Target/Specificity Lane 2: HT-29 whole cell lysate Lane 3: U-2 This ADD1 antibody is generated from a OS whole cell lysate Lysates/proteins at 20 rabbit immunized with a KLH conjugated µg per lane. Secondary Goat Anti-Rabbit IgG, synthetic peptide between 428-462 amino (H+L), Peroxidase conjugated at 1/10000 acids from the Central region of human dilution. Predicted band size : 81 kDa ADD1. Blocking/Dilution buffer: 5% NFDM/TBST. Dilution WB~~1:2000 FC~~1:25 Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. Storage Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C Overlay histogram showing A431 cells in small aliquots to prevent freeze-thaw stained with AP22310c(green line). The cells cycles. were fixed with 2% paraformaldehyde and then permeabilized with 90% methanol for 10 Precautions min. The cells were then incubated in 2% ADD1 Antibody (Center) is for research use bovine serum albumin to block non-specific only and not for use in diagnostic or protein-protein interactions followed by the therapeutic procedures.
[Show full text]
Systematic Analysis, Comparison, and Integration of Disease Based Human
Zhang et al. BMC Medical Genomics 2010, 3:1 http://www.biomedcentral.com/1755-8794/3/1 RESEARCH ARTICLE Open Access Systematic analysis, comparison, and integration of disease based human genetic association data and mouse genetic phenotypic information Yonqing Zhang1†, Supriyo De1†, John R Garner1, Kirstin Smith1, S Alex Wang2, Kevin G Becker1* Abstract Background: The genetic contributions to human common disorders and mouse genetic models of disease are complex and often overlapping. In common human diseases, unlike classical Mendelian disorders, genetic factors generally have small effect sizes, are multifactorial, and are highly pleiotropic. Likewise, mouse genetic models of disease often have pleiotropic and overlapping phenotypes. Moreover, phenotypic descriptions in the literature in both human and mouse are often poorly characterized and difficult to compare directly. Methods: In this report, human genetic association results from the literature are summarized with regard to replication, disease phenotype, and gene specific results; and organized in the context of a systematic disease ontology. Similarly summarized mouse genetic disease models are organized within the Mammalian Phenotype ontology. Human and mouse disease and phenotype based gene sets are identified. These disease gene sets are then compared individually and in large groups through dendrogram analysis and hierarchical clustering analysis. Results: Human disease and mouse phenotype gene sets are shown to group into disease and phenotypically relevant groups at both a coarse and fine level based on gene sharing. Conclusion: This analysis provides a systematic and global perspective on the genetics of common human disease as compared to itself and in the context of mouse genetic models of disease.
[Show full text]
Genomic Profiling Maps Loss of Heterozygosity and Defines the Timing and Stage Dependence of Epigenetic and Genetic Events in Wilms’ Tumors
Genomic Profiling Maps Loss of Heterozygosity and Defines the Timing and Stage Dependence of Epigenetic and Genetic Events in Wilms’ Tumors Eric Yuan,1 Chi-Ming Li,1 Darrell J. Yamashiro,2 Jessica Kandel,3 Harshwardhan Thaker,4 Vundavalli V. Murty,4 and Benjamin Tycko1,4 1Institute for Cancer Genetics; 2Department of Pediatrics, Division of Pediatric Oncology; 3Department of Surgery, Division of Pediatric Surgery; and 4Department of Pathology, Columbia University Medical Center, New York, New York Abstract Introduction To understand genetic and epigenetic pathways in Since 1972 when Knudson and Strong analyzed epidemio- Wilms’ tumors, we carried out a genome scan for loss logic data from Wilms’ tumor to develop the concept of tumor of heterozygosity (LOH) using Affymetrix 10K single suppressor genes (1), research on this pediatric kidney tumor nucleotide polymorphism (SNP) chips and has continued to uncover important principles in cancer supplemented the data with karyotype information. genetics. Early findings were the recognition of the Wilms’ To score loss of imprinting (LOI) of the IGF2 gene, we tumor-aniridia (WAGR) syndrome and its mapping to chromo- assessed DNA methylation of the H19 5V differentially some 11p13 (2-4) and the discovery of the WT1 tumor methylated region (DMR). Few chromosomal regions suppressor gene in that chromosome band (5-7). WT1 is other than band 11p13 (WT1) were lost in Wilms’ mutated in f10% of Wilms’ tumors overall, predominantly in tumors from Denys-Drash and Wilms’ tumor-aniridia the setting of WAGR and Denys-Drash syndromes but also in a syndromes, whereas sporadic Wilms’ tumors showed small subset of sporadic Wilms’ tumors (8-10).
[Show full text]